238 related articles for article (PubMed ID: 35130317)
1. Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
Lerkvaleekul B; Apiwattanakul N; Tangnararatchakit K; Jirapattananon N; Srisala S; Vilaiyuk S
PLoS One; 2022; 17(2):e0263536. PubMed ID: 35130317
[TBL] [Abstract][Full Text] [Related]
2. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Smith EMD; Jorgensen AL; Beresford MW;
Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
[TBL] [Abstract][Full Text] [Related]
3. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
[TBL] [Abstract][Full Text] [Related]
5. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
[TBL] [Abstract][Full Text] [Related]
6. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE.
Robinson GA; Waddington KE; Coelewij L; Peng J; Naja M; Wincup C; Radziszewska A; Peckham H; Isenberg DA; Ioannou Y; Ciurtin C; Pineda-Torra I; Jury EC
EBioMedicine; 2021 Mar; 65():103243. PubMed ID: 33640328
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study.
Hsu TC; Yang YH; Wang LC; Lee JH; Yu HH; Lin YT; Hu YC; Chiang BL
Pediatr Rheumatol Online J; 2023 Mar; 21(1):28. PubMed ID: 36964531
[TBL] [Abstract][Full Text] [Related]
8. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
Massias JS; Smith EM; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2021 Apr; 30(4):597-607. PubMed ID: 33413005
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.
Smith EMD; Yin P; Jorgensen AL; Beresford MW;
Pediatr Rheumatol Online J; 2018 Feb; 16(1):14. PubMed ID: 29467038
[TBL] [Abstract][Full Text] [Related]
11. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
Artim-Esen B; Şahin S; Çene E; Şahinkaya Y; Barut K; Adrovic A; Özlük Y; Kılıçaslan I; Omma A; Gül A; Öcal L; Kasapçopur Ö; İnanç M
J Rheumatol; 2017 May; 44(5):619-625. PubMed ID: 28298568
[TBL] [Abstract][Full Text] [Related]
13. Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus.
Yamada J; Peracchi OA; Terreri MT; de Moraes-Pinto MI
Lupus; 2022 Sep; 31(10):1237-1244. PubMed ID: 35849633
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?
Kanakoudi-Tsakalidou F; Farmaki E; Tzimouli V; Taparkou A; Paterakis G; Trachana M; Pratsidou-Gertsi P; Nalbanti P; Papachristou F
Lupus; 2014 Mar; 23(3):305-12. PubMed ID: 24399813
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.
Smith EMD; Yin P; Jorgensen AL; Beresford MW
Lupus; 2018 Nov; 27(13):2020-2028. PubMed ID: 30246602
[TBL] [Abstract][Full Text] [Related]
16. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients.
Eissa E; Kandil R; Dorgham D; Ghorab R; Kholoussi N
Pediatr Rheumatol Online J; 2024 Jan; 22(1):20. PubMed ID: 38243322
[TBL] [Abstract][Full Text] [Related]
18. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
[TBL] [Abstract][Full Text] [Related]
19. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients.
Abdelrahman N; Beresford MW; Leone V;
Lupus; 2019 Apr; 28(5):667-674. PubMed ID: 30943853
[TBL] [Abstract][Full Text] [Related]
20. The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus.
Ballantine LE; Ong J; Midgley A; Watson L; Flanagan BF; Beresford MW
Pediatr Rheumatol Online J; 2014 Jan; 12():4. PubMed ID: 24433387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
